Alyeska Investment Group, L.P. Pfizer Inc Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $50.5 Million - $59.2 Million	2,000,000 New	2,000,000 $56 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $5.36 Million - $6.96 Million	205,104 New	205,104 $5.9 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $42.9 Million - $52 Million	-1,422,945 Reduced 65.04%	764,913 $23.7 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $59.1 Million - $84.5 Million	2,187,858 New	2,187,858 $67.8 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.